Vaccines Makers Start Preparing for Bird Flu Shots ‘Just in Case’
As the world continues to grapple with the ongoing COVID-19 pandemic, vaccine manufacturers are already preparing for the possibility of another pandemic caused by avian influenza, also known as bird flu. Several major pharmaceutical companies are developing vaccines for bird flu in anticipation of a potential outbreak. Bird flu is a type of influenza that primarily affects birds but can occasionally be transmitted to humans. While human cases of bird flu are rare, the virus has the potential to mutate and become more contagious, leading to a potential pandemic. Pharmaceutical companies have been monitoring the spread of bird flu for years and have been preparing for the possibility of an outbreak. Companies like GlaxoSmithKline, Sanofi, and Seqirus are among those developing bird flu vaccines , which are designed to be used in the event of an outbreak. Which vaccines are in the process of development? The vaccines currently in development are based on the H5N1 strain of the virus, whi...